Viewing StudyNCT00023881



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00023881
Status: TERMINATED
Last Update Posted: 2018-11-14
First Post: 2001-09-13

Brief Title: Bortezomib in Treating Patients With Chronic Myelogenous Leukemia
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Conditions & Keywords Data

Conditions:
Name
Leukemia
Keywords:
Name View
relapsing chronic myelogenous leukemia View
chronic phase chronic myelogenous leukemia View
accelerated phase chronic myelogenous leukemia View
chronic myelogenous leukemia BCR-ABL1 positive View